How Technology is Transforming the Arteriovenous Malformation Market
Technological advancements are revolutionizing the Arteriovenous Malformation Market. Innovations in endovascular embolization, stereotactic radiosurgery, and image-guided therapies are improving precision and patient outcomes.
Integration of advanced imaging modalities allows clinicians to identify complex AVMs with higher accuracy, enabling targeted treatment and reducing complications. These technologies also streamline procedures, making treatments safer and more efficient.
Market Outlook: Valued at USD 1.1 billion in 2024, the market is expected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.
1 View